Glycoproteomic Serum Profiles: Accurate Detection of Advanced Adenomas for Early Colorectal Cancer Diagnosis
Glycoproteomic serum profiles accurately detect advanced adenomas, setting it apart from other blood-based assays for early colorectal cancer detection. It relies on aberrant protein glycosylation pathways, offering high sensitivity. AI-powered data processing enables rapid interpretation of biomarkers. A machine learning model achieved 91% sensitivity and 92% accuracy in identifying affected individuals. Further research is needed to evaluate its potential role in clinical practice.